Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?

Area of Science:

• Immunology
• Neurobiology
• Pathophysiology of Multiple Sclerosis

Background:

• T cell cytokine phenotypes are diverse, but their role in MS pathogenesis remains debated.
• While Th1 (IFNγ) and Th17 (IL-17) cells are implicated, their specific cytokines may not be the primary drivers of T cell encephalitogenicity in MS.

Purpose of the Study:

• To investigate the critical factors determining T cell encephalitogenicity in multiple sclerosis.
• To identify key molecular pathways upstream of Th1 and Th17 cell differentiation that drive central nervous system inflammation in MS.

Main Methods:

• The study reviews existing literature on T cell responses and molecular pathways in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS).
• It analyzes the roles of molecules like IL-23, T-bet, and STAT4 in T cell activation and trafficking to the CNS.

Main Results:

• IFNγ and IL-17 produced by Th1 and Th17 cells, respectively, do not appear to be the critical determinants of T cell encephalitogenicity.
• Molecules such as IL-23, T-bet, and STAT4 seem critical, but their exact contribution to a common or synergistic pathway remains undetermined.

Conclusions:

• The critical determinants of T cell encephalitogenicity in MS likely lie in pathways upstream of IFNγ and IL-17 production.
• Future research should focus on these upstream pathways to better understand and target the trafficking and inflammatory potential of effector T cells in the CNS in MS.